Crownlink
Databases
Biospecimen Request

Our Services

Oncology & IO Solutions

Preclinical Services

Patient-Derived Translational Oncology

Biomarker & Bioanalysis Services

Clinical Biomarker & Biospecimen Services

Bioinformatics & Data Solutions

Therapeutic Modalities

ADCs

Cell & Gene Therapy

Radiopharmaceuticals

Cancer Indications

AML / Liquid Tumors

Breast Cancer

Drug Targets

KRAS

EGFR

IO Targets

PARP

Drug Resistance

Drug Combinations

Drug Discovery

Target Discovery & Validation

Drug Screening

Efficacy

Pharmacology

In Silico Solutions

Consulting

In Vitro Services

Cell Lines & Panels

OmniScreen

Patient-derived Organoids

Organoid Xplore

Drug Screening & Combination Analysis

Complex IO Assays

High Content Imaging

DMPK / Tox

In Vivo DMPKT

Bioanalysis

Engineered Models & Services

Target KO & CRISPR

In Vivo Services

PDX Models

CDX Models

Syngeneic Models

Humanized GEMMs

Tumor Homografts

Humanized Models
(HSC & PBMC)

Orthotopic / Metastatic &
Imaging-enabled Models

Imaging Technology

Digital Pathology

High Content Imaging

Patient Derived Systems

PDX Mouse Clinical Trials

Organoid and Matched PDX

Ex Vivo Patient Tissue

3D Bone Marrow Models

Biomarker Discovery Services

OmniScreen

Organoid Xplore

PDX Mouse Clinical Trials

Spatial Biology &
Tissue-based Biomarker Analysis

Histology & Immunostaining
(H&E, IHC, IF, mIF)

NanoString GeoMx

10x Genomics Visium

Tumor Tissue Microarrays

Digital Pathology

Protein Analysis

Immunoassays
(ELISA, MSD, Luminex)

Flow Cytometry

Mass Spec-proteomics

Discovery Proteomics

PTM Proteomics & Phosphoproteomics

Rare Cell Analysis

DNA / RNA Analysis

Standard Genomics

Next Generation Sequencing

Single Cell Sequencing

NanoString nCounter

Optical Genome Mapping

Mouse I/O RNA-seq Panel

Microbiome Sequencing

NanoString GeoMx

10x Genomics Visium

Cell Line Authentication

Model-derived Biobank

Tumor Tissue Microarrays

Immune Monitoring

Bioanalysis

Biofluid Testing

Regulatory Accreditations

Specialty Biomarker Services

Longitudinal Plasma

Clinical Biomarkers

Human Biospecimens

Preclinical Cancer Model Databases

Drug Combinations

Bioinformatics Consulting

Preclinical Biomarker Discovery

Omics Data Analysis
- Oncology & IO Solutions
- Preclinical Services
- Patient-Derived Translational Oncology
- Biomarker & Bioanalysis Services
- Clinical Biomarker & Biospecimen Services
- Bioinformatics & Data Solutions
Publications & Resources

Blog

Podcast

Publications

Resources
About Us

Company

Leadership & SAB

News & Events

Careers

Awards & Testimonials

Crownlink
Databases
Biospecimen Request

Contact Us

Contact Us

This is a search field with an auto-suggest feature attached.

There are no suggestions because the search field is empty.

Crown Bioscience News & Events

May 4, 2011

Crown Bioscience, Inc. Announces Closing of Series C Financing

Apr 1, 2011

Allostem Therapeutics Teams with Crown Biosciences for Phase 0 Oncology Model Selection to Accelerate MEK Inhibitor Program

Dec 7, 2010

Crown Biosciences Announces Partnership With Jasco Pharmaceuticals to Develop Oncology Programs

Jul 12, 2010

Crown Bioscience Introduces New Informational Site Feature

Mar 1, 2010

Crown Bioscience Adds Former Distinguished Eli Lilly Scholar to its Senior Management Team

Prev 1 ... 26 27 28 29 30

Oncology & I/O Solutions
Preclinical Services
Patient-Derived Translational Oncology
- Patient Derived Systems
- Biomarker Discovery Services
Biomarker & Bioanalysis Services
Clinical Biomarker & Biospecimen Services
Bioinformatics & Data Solutions

© 2026 Crown Bioscience. All Rights Reserved.

About Us
Contact Us
Privacy Policy
Imprint
Terms of Service
Privacy Preferences